ATE406873T1 - Zusammensetzung zur behandlung entzündlicher erkrankungen - Google Patents

Zusammensetzung zur behandlung entzündlicher erkrankungen

Info

Publication number
ATE406873T1
ATE406873T1 AT03733628T AT03733628T ATE406873T1 AT E406873 T1 ATE406873 T1 AT E406873T1 AT 03733628 T AT03733628 T AT 03733628T AT 03733628 T AT03733628 T AT 03733628T AT E406873 T1 ATE406873 T1 AT E406873T1
Authority
AT
Austria
Prior art keywords
treatment
composition
inflammatory diseases
forming lipids
liposomes
Prior art date
Application number
AT03733628T
Other languages
English (en)
Inventor
Josbert Metselaar
Original Assignee
Enceladus Pharmaceuticals B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enceladus Pharmaceuticals B V filed Critical Enceladus Pharmaceuticals B V
Application granted granted Critical
Publication of ATE406873T1 publication Critical patent/ATE406873T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03733628T 2002-06-12 2003-06-11 Zusammensetzung zur behandlung entzündlicher erkrankungen ATE406873T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02077338A EP1371362A1 (de) 2002-06-12 2002-06-12 Zusammensetzung zur Behandlung entzündlicher Erkrankungen

Publications (1)

Publication Number Publication Date
ATE406873T1 true ATE406873T1 (de) 2008-09-15

Family

ID=29558396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03733628T ATE406873T1 (de) 2002-06-12 2003-06-11 Zusammensetzung zur behandlung entzündlicher erkrankungen

Country Status (8)

Country Link
EP (2) EP1371362A1 (de)
JP (1) JP4564844B2 (de)
AT (1) ATE406873T1 (de)
AU (1) AU2003238716B2 (de)
CA (1) CA2489269C (de)
DE (1) DE60323369D1 (de)
ES (1) ES2314210T3 (de)
WO (1) WO2003105805A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1347743T3 (da) 2000-12-07 2006-07-03 Univ Utrecht Holding Bv Præparat til behandling af inflammatoriske lidelser
DE10255106A1 (de) * 2002-11-24 2004-06-09 Novosom Ag Liposomale Glucocorticoide
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
WO2006027787A1 (en) * 2004-09-09 2006-03-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal compositions of glucocorticoid and glucocorticoid derivatives
CA2595731A1 (en) * 2005-01-26 2006-08-03 Celator Pharmaceuticals, Inc. Lipid carrier compositions with reduced polydispersity
EP2127639A1 (de) * 2008-05-26 2009-12-02 Universiteit Utrecht Holding B.V. Corticosteroid enthaltende Liposomen zur Behandlung von kardiovaskulären Erkrankungen
WO2010148262A1 (en) * 2009-06-17 2010-12-23 Mark Rutenberg Treatment of acute pulmonary inflammation induced by cigarette smoking
CA2800693A1 (en) 2010-05-28 2011-12-01 Purdue Research Foundation Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
US9144575B2 (en) 2010-07-28 2015-09-29 Life Technologies Corporation Anti-viral azide containing compounds
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
ES2701748T3 (es) * 2011-11-04 2019-02-25 Enceladus Pharmaceuticals B V Corticoesteroides liposomales para el tratamiento de trastornos inflamatorios en humanos
AU2013212068B2 (en) 2012-01-26 2018-02-15 Life Technologies Corporation Methods for increasing the infectivity of viruses
SI2854769T1 (sl) * 2012-07-05 2023-09-29 Taiwan Liposome Company, Ltd. Postopki za zdravljenje artritisa
JP2019515925A (ja) 2016-04-29 2019-06-13 エンセラドゥス ファーマセウティカルス べー．フェー． 炎症性病変又は領域に局所注射するためのリポソーム化コルチコステロイド
EP3849522A1 (de) * 2018-09-16 2021-07-21 TLC Biopharmaceuticals, Inc. Pharmazeutische zusammensetzungen zur gelenkverabreichung und verwendung davon zur behandlung von gelenkschmerzen
WO2021041374A1 (en) * 2019-08-28 2021-03-04 Cai Gu Huang Liposome formulation of fluticasone furoate and method of preparation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US6316260B1 (en) * 1997-08-22 2001-11-13 Bernina Biosystems Gmbh Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof
JP4827277B2 (ja) * 1998-11-02 2011-11-30 テルモ株式会社 リポソーム
DE69825495T2 (de) * 1998-12-23 2005-07-28 Idea Ag Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
JP2001064158A (ja) * 1999-06-25 2001-03-13 Terumo Corp リポソーム
EP1190706B1 (de) * 1999-06-25 2009-05-06 Terumo Kabushiki Kaisha Liposome
DK1347743T3 (da) * 2000-12-07 2006-07-03 Univ Utrecht Holding Bv Præparat til behandling af inflammatoriske lidelser

Also Published As

Publication number Publication date
EP1371362A1 (de) 2003-12-17
EP1517675A1 (de) 2005-03-30
CA2489269C (en) 2012-01-17
ES2314210T3 (es) 2009-03-16
JP2005534663A (ja) 2005-11-17
DE60323369D1 (de) 2008-10-16
JP4564844B2 (ja) 2010-10-20
EP1517675B1 (de) 2008-09-03
AU2003238716A1 (en) 2003-12-31
WO2003105805A1 (en) 2003-12-24
AU2003238716B2 (en) 2009-10-08
CA2489269A1 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
DE60323369D1 (de) Zusammensetzung zur behandlung entzündlicher erkrankungen
ATE319428T1 (de) Zusammensetzung zur behandlung von entzündlichen erkrankungen
EP1539246A4 (de) Verabreichung in die zentralen luftwege zur systemischen abgabe von therapeutika
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
BG106586A (en) Pyrazolopyramidines as therapeutic agents
JO2371B1 (en) 4-phenyl-pyridine derivatives
BR0311585A (pt) Sistema de fornecimento de drogas, método para administrar uma droga oftálmica a um paciente, kit, uso do mesmo, método para preparar o sistema de fornecimento de drogas, e, artigo de fabricação
DK0738270T3 (da) Dihydropyrazolopyrroler
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
SG148846A1 (en) Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimeræs and related neurodegenerative disorders
GT200100214A (es) Inhibidores de metaloproteinasa del tipo pirimidin-2,4,6-triona
IL173129A0 (en) 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
CY1106645T1 (el) Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος
IL152770A0 (en) Gabapentin analogues for sleep disorders
AR026487A1 (es) Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del snc
HUT62192A (en) Process for producing pharmaceutical compositions comprising tomoxetine and suitable for treating diseases of lower urinary tract
WO2005003103A3 (en) 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
TR200003122T2 (tr) Aril bağlı azapolisiklik bileşikler
WO2003059376A8 (en) The use of il6r/il6 chimera in nerve cell regeneration
ATE367390T1 (de) Phenylalanin enamidderivate
GB0004152D0 (en) Novel compounds
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties